- Home
- ALDX vs ACRE Comparison
ALDX vs ACRE Comparison
Compare ALDX & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- ACRE
- Stock Information
- Founded
- ALDX 2004
- ACRE 2011
- Country
- ALDX United States
- ACRE United States
- Employees
- ALDX N/A
- ACRE N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- ACRE Real Estate Investment Trusts
- Sector
- ALDX Health Care
- ACRE Real Estate
- Exchange
- ALDX Nasdaq
- ACRE Nasdaq
- Market Cap
- ALDX 160.8M
- ACRE 270.6M
- IPO Year
- ALDX 2014
- ACRE 2012
- Fundamental
- Price
- ALDX $4.76
- ACRE $4.75
- Analyst Decision
- ALDX Strong Buy
- ACRE Hold
- Analyst Count
- ALDX 2
- ACRE 7
- Target Price
- ALDX $9.50
- ACRE $5.58
- AVG Volume (30 Days)
- ALDX 1.2M
- ACRE 473.8K
- Earning Date
- ALDX 07-31-2025
- ACRE 08-05-2025
- Dividend Yield
- ALDX N/A
- ACRE 12.67%
- EPS Growth
- ALDX N/A
- ACRE N/A
- EPS
- ALDX N/A
- ACRE N/A
- Revenue
- ALDX N/A
- ACRE $67,129,000.00
- Revenue This Year
- ALDX N/A
- ACRE N/A
- Revenue Next Year
- ALDX N/A
- ACRE N/A
- P/E Ratio
- ALDX N/A
- ACRE N/A
- Revenue Growth
- ALDX N/A
- ACRE 83.51
- 52 Week Low
- ALDX $1.14
- ACRE $3.35
- 52 Week High
- ALDX $7.20
- ACRE $7.99
- Technical
- Relative Strength Index (RSI)
- ALDX 78.74
- ACRE 45.61
- Support Level
- ALDX $4.12
- ACRE $4.68
- Resistance Level
- ALDX $4.60
- ACRE $4.89
- Average True Range (ATR)
- ALDX 0.29
- ACRE 0.15
- MACD
- ALDX 0.08
- ACRE -0.03
- Stochastic Oscillator
- ALDX 90.91
- ACRE 7.32
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.